Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Regenerative cosmetics can improve skin and hair by reducing wrinkles, healing wounds, and promoting hair growth.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Finasteride causes reduced tear flow and severe eye inflammation.